Brief: Bicycle Therapeutics Announces Bt5528 Phase I Dose Escalation Results In Patients With Advanced Solid Tumors
07/09/2022 12:23
Sept 7 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS ANNOUNCES BT5528 PHASE I DOSE
ESCALATION
RESULTS IN PATIENTS WITH ADVANCED SOLID TUMORS
Source text for Eikon: ID:nBwbBL5rTa
Further company coverage: BCYC.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics Q1 revenue drops after partnership terminations
Brief: Bicycle Therapeutics Announces Oral And Poster Presentations At The Aacr Annual Meeting 2026
UK's Bicycle Therapeutics Q4 revenue jumps, proposes 30% workforce reduction
Brief: Bicycle Therapeutics Says Travis Thompson Appointed As CFO, Succeeds Alethia Young
Bicycle Therapeutics Q3 net loss widens as R&D costs rise